Illumina's NovaSequ 6000 S1 reagent kit and the free adapter Blocking Reagent kit
Closed Pre-Solicitation Posted
- Solicitation number
- NOI-NIAID-1932833
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93018P01345 Federal contract award
- Awardee
- Illumina, Inc.
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Not on record
- Place of performance
- 9000 Rockville Pike Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Illumina, Inc. to procure NovaSequ 6000 S1 reagent kit and the free adapter Blocking Reagent kit. These kits are used by The Center for Human Immunology, Autoimmunity and Inflammation (CHI), under the NIAID, is involved in the study and characterization of both normal and pathogenic immunome.
The statutory authority for this sole source requirement is 41 U.S.C. 1901(e)(2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-1932833) to Laura Grey at laura.grey@nih.gov, by 5:00 pm eastern standard time Friday September 14, 2018. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity